Original ArticleHistone Deacetylase Inhibitor Romidepsin Enhances Anti-Tumor Effect of Erlotinib in Non-small Cell Lung Cancer (NSCLC) Cell Lines
Under an Elsevier user license
open archive
Key Words:
Erlotinib
Romidepsin
Non-small cell lung cancer
Epidermal growth factor receptor
KRAS
Cited by (0)
Disclosure: The authors declare no conflicts of interest.
Copyright © 2009 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.